Supreme Court To Reconsider “Rules Of the Road” In Generic Preemption
This article was originally published in The Pink Sheet Daily
Executive Summary
Design defect claims made against generic companies are focus of a case involving Mutual Pharmaceutical’s generic sulindac; ruling may eliminate lower court carve-outs to its Mensing decision.